HC Wainwright reaffirmed their buy rating on shares of CollPlant Biotechnologies (NASDAQ:CLGN – Free Report) in a research note published on Friday, Benzinga reports. The brokerage currently has a $11.00 price target on the stock. CollPlant Biotechnologies Price Performance CLGN stock opened at $6.92 on Friday. The stock has a market capitalization of $76.74 million […]
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Get Free Report) was the recipient of a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 7,200 shares, an increase of 71.4% from the July 31st total of 4,200 shares. Based on an average daily trading volume, of 13,800 […]
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Free Report) was the recipient of a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 11,600 shares, a decrease of 53.0% from the May 31st total of 24,700 shares. Approximately 0.2% of the company’s shares are sold short. Based […]
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Get Rating) was the recipient of a large increase in short interest in May. As of May 31st, there was short interest totalling 24,700 shares, an increase of 42.0% from the May 15th total of 17,400 shares. Based on an average daily volume of 8,500 shares, the days-to-cover ratio is […]
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Get Rating) saw a large decrease in short interest in March. As of March 31st, there was short interest totalling 21,800 shares, a decrease of 12.1% from the March 15th total of 24,800 shares. Currently, 0.3% of the company’s stock are sold short. Based on an average daily trading volume, […]